FAPI PET Imaging in Nonischemic Cardiomyopathy

Study acronym: FAPI-NICM
StatusRecruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to evaluate the clinical value of \[¹⁸F\]AlF-NOTA-FAPI-04 PET/CT for the noninvasive assessment of myocardial fibroblast activation in patients with nonischemic cardiomyopathy. The study will investigate whether \[¹⁸F\]AlF-NOTA-FAPI-04 PET/CT can provide complementary information for disease phenotyping, assessment of treatment response, and prognostic risk stratification in nonischemic cardiomyopathy.
Trial Details
NCT Number NCT07878338
Lead Sponsor Peking Union Medical College Hospital
Conditions
(from sponsor)		 Nonischemic Cardiomyopathy
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov